Drug Profile
C-peptide long-acting - Cebix
Alternative Names: CBX 129801; Ersatta; PEGylated C-peptideLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Cebix
- Class Pancreatic hormones
- Mechanism of Action Adenosine triphosphatase stimulants; Nerve growth factor stimulants; Nitric oxide synthase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetic neuropathies
Most Recent Events
- 01 Jan 2015 Cebix completes a phase II trial in Diabetic neuropathies in USA, Canada and Sweden (NCT01681290)
- 11 Dec 2012 Phase-II clinical trials in Diabetic neuropathies in Sweden (SC) (EudraCT2012-001246-17)
- 11 Dec 2012 Phase-II clinical trials in Diabetic neuropathies in Canada (SC)